Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Appendix B: Panel Roster and Financial Disclosures
Last Updated: January 1, 2020; Last Reviewed: August 1, 2019
|Boyd, Sarita||Food and Drug Administration||None||N/A|
|Chow, Felicia||University of California, San Francisco||None||N/A|
|Kovacs, Joe*||National Institutes of Health||Matinas BioPharma||Research Support|
|Kuruppu, Janaki||National Institutes of Health||None||N/A|
|Lai, Leon||Washington Hospital Center||None||N/A|
|Miro, Jose M.||Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain||None||N/A|
||Hospital Universitari de Bellvitge, Barcelona, Spain
|* Group lead
Note: Members were asked to disclose all relationships from 12 months prior to the update date. The period of reporting was from August 1, 2018, through August 1, 2019.
- CDC | 2015 STD Treatment Guidelines
- HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
- AIDSinfo Patient Materials: What is an Opportunistic Infection?
- AIDSource | HIV-Related Conditions
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Adult and Adolescent OI Guidelines Archive